Barclays Maintains Equal-Weight on Colgate-Palmolive, Raises Price Target to $84
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman maintains an Equal-Weight rating on Colgate-Palmolive (NYSE:CL) and raises the price target from $82 to $84.
April 12, 2024 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays maintains an Equal-Weight rating on Colgate-Palmolive and raises the price target from $82 to $84.
The increase in price target by Barclays reflects a positive outlook on Colgate-Palmolive's stock, potentially leading to short-term price appreciation. The maintenance of an Equal-Weight rating suggests a balanced view on the stock's current valuation, indicating that while there may be upside potential, significant risks or overvaluation concerns may still exist. This adjustment in price target could lead to increased investor interest and a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100